Holocaust survivors have a small but significant increased risk for cancer, show findings of a study comparing individuals who were entitled to compensation for suffering persecution during the war with individuals denied such compensation.

Click through to read more on this US FDA decision

Spanish researchers who observed hair repigmentation among patients with non-small-cell lung cancer who responded to immunotherapeutic drugs against programmed cell death protein 1 and its ligand believe that the side effect could serve as a potential marker of response.

Nearly a quarter of all cancers diagnosed in the European Union between 2000 and 2007 were classed as rare, according to updated epidemiologic information from the Information Network on Rare Cancers.

The 70-gene MammaPrint assay can identify women who have an ultralow risk for death from breast cancer in the long term, potentially allowing their physicians to choose less aggressive treatment, say researchers.

All-cause and prostate cancer-specific mortality rates remain comparable over nearly 2 decades of follow-up among men with early prostate cancer regardless of whether they undergo radical prostatectomy or observation, the PIVOT trial shows.